The Financial Times and PBS have debuted “Opioids Inc.,” a combined investigation into the role one pharmaceutical company played in fueling America’s epidemic of opioid addiction, and how it and its stockholders profited from it.
This is the first-ever collaboration between “Frontline” and the FT, while demonstrating the latter’s continued investment to engage audiences in the U.S.
The joint investigation launches with a free, in-depth magazine cover story from the FT, followed by streaming of the “Opioids Inc.” documentary and concluding with a television debut on PBS “Frontline” on June 23.
“‘Opioids Inc.’ is a deeply investigated collaboration between two influential news organisations into a story about corporate misconduct and its social ramifications,” said Kayode Josiah, director of commercial development at the FT. “This partnership allows the FT to further its presence in the US while leveraging both its world class journalism and the strength of a trusted brand that is PBS.”
“Opioids Inc.” can be watched in full at pbs.org/frontline and in the PBS Video App for American audiences. It will also be available online for two weeks for viewers in U.K.
Wall Street Journal reporter Hannah Miao is moving to Singapore to cover the China economy.…
Financial Times reporter Simon Foy is now covering European banks. He has been covering accounting for the…
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…